LINC01133 and gastric cancer: For instance, LINC01133 inhibits epithelial–mesenchymal transition in gastric cancer cells and cancer metastasis via functioning as a sponge of miR-106a, thereby increasing the levels of adenomatous polyposis coli (APC) [34].